You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NEN

Showing 1 - 25 of 64
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Financial Toxicity and Patient-Reported Outcomes in GEP-NEN

Recruiting
  • Neuroendocrine Tumors
    • Milan, Italy
      IRCCS Ospedale San Raffaele
    Apr 16, 2022

    Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Germany (Cabozantinib)

    Recruiting
    • Neuroendocrine Tumors
    • Neuroendocrine Carcinoma
    • Göttingen, Lower Saxony, Germany
    • +5 more
    Jun 27, 2022

    Neuroendocrine Tumor Trial in Beijing (PM8002, FOLFIRI)

    Recruiting
    • Neuroendocrine Neoplasm
    • Beijing, China
      Chinese PLA General Hospital
    May 25, 2023

    Solid Tumors Trial (HBM4003, Toripalimab)

    Not yet recruiting
    • Solid Tumors
    • (no location specified)
    Jan 12, 2022

    Cancer Trial in Heidelberg, Mainz (combination of Avelumab and Cabozantinib)

    Recruiting
    • Cancer
    • combination of Avelumab and Cabozantinib
    • Heidelberg, Germany
    • +1 more
    Mar 31, 2022

    Neuroendocrine Tumor Grade 3, Neuroendocrine Carcinoma, Pancreatic Carcinoma Trial in Tianjin (Surufatinib, Sintilimab)

    Recruiting
    • Neuroendocrine Tumor Grade 3
    • +2 more
    • Tianjin, Tianjin, China
      Rui Liu
    Nov 17, 2022

    Neuroendocrine Tumor Trial in Aarhus (Lu-177-DOTA-Octreotide)

    Recruiting
    • Neuroendocrine Neoplasm
    • Aarhus, Palle Juul-Jensens Boulevard, Denmark
      Aarhus University Hospital, department of Nuclear medicine and P
    Jun 7, 2021

    Registry on NEN Patients and COVID-19

    Recruiting
    • Neuroendocrine Tumors
    • COVID-19
      • Milan, MI, Italy
        European Institute of Oncology, IEO, IRCCS
      Aug 12, 2021

      PFS and OS of Advanced Neuroendocrine Cancer After Systemic

      Recruiting
      • Neuroendocrine Tumors
        • Olsztyn, Warmińsko-Mazurskie, Poland
        • +1 more
        May 12, 2021

        Early Treatment Response in NEN (REBORN)

        Recruiting
        • Neuroendocrine Tumors
        • +4 more
        • Somatostatin analog; chemotherapy
        • Rome, Italy
          Andrea M Isidori
        Dec 2, 2020

        Neuroendocrine Tumors Trial in Innsbruck, Kraków, Ljubljana ([99mTc]Tc-TECANT1)

        Recruiting
        • Neuroendocrine Tumors
        • Innsbruck, Austria
        • +2 more
        May 12, 2023

        GEP-NET, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, 64Cu-Dotatate)

        Enrolling by invitation
        • GEP-NET
        • +3 more
        • Copenhagen, Denmark
          Rigshospitalet
        Jan 24, 2023

        Neuroendocrine Tumors Trial in Beijing (177Lu-Dotatate PRRT)

        Unknown status
        • Neuroendocrine Tumors
        • 177Lu-Dotatate PRRT
        • Beijing, Beijing, China
          Beijing Cancer Hospital
        Feb 5, 2020

        Neuroendocrine Neoplasms Methylation Based Classifier - The

        Enrolling by invitation
        • Neuroendocrine Tumors
        • Methylation analysis
        • Basel, Basel Stadt, Switzerland
          University Hospital Basel, Department of Endocrinology
        May 17, 2022

        Models in Neuroendocrine Neoplasm

        Recruiting
        • Neuroendocrine Neoplasm
        • Biopsy, open or laparoscopic surgery
        • Shanghai, Shanghai, China
          Department of Pancreatic Surgery, Fudan University Shanghai Canc
        Sep 19, 2021

        Neuroendocrine Neoplasm Based on Multi-omics Integrated Analysis

        Not yet recruiting
        • Neuroendocrine Neoplasm
        • Biopsy/surgical tissue and peripheral blood
        • Shanghai, Shanghai, China
          Department of Pancreatic Surgery, Fudan University Shanghai Canc
        Jun 12, 2021

        Neuroendocrine Tumors, Frailty, Chemo Effect Trial in Milan (Temozolomide capsule)

        Recruiting
        • Neuroendocrine Tumors
        • +2 more
        • Temozolomide capsule
        • Milan, Italy
          European Institute of Oncology, IEO, IRCCS
        Sep 21, 2022

        Neuroendocrine Tumors Trial in Sweden (177Lu-DOTATOC, Capecitabine)

        Not yet recruiting
        • Neuroendocrine Tumors
        • Göteborg, Sweden
        • +3 more
        May 19, 2022

        Quality of Life Trial in Belgium (EORTC QLQ-C30, EORTC QLQ-GI.NET21, Satisfaction survey)

        Recruiting
        • Quality of Life
        • EORTC QLQ-C30
        • +2 more
        • Brasschaat, Antwerp, Belgium
        • +6 more
        Mar 8, 2022

        Neuroendocrine Tumors Trial in Beijing (Surufatinib Combined With Temozolomide and S-1)

        Not yet recruiting
        • Neuroendocrine Tumors
        • Surufatinib Combined With Temozolomide and S-1
        • Beijing, Beijing, China
          Cancer Institute and Hospital, Chinese Academy of Medical Scienc
        Sep 8, 2023

        Surufatinib in G3 Neuroendocrine Tumors

        Not yet recruiting
        • Neuroendocrine Tumor Grade 3
        • (no location specified)
        Aug 2, 2023

        Healthy Nurses, Educational Activities Trial in Amman (Simulation in basic life support training (SBLST), standard treatment by

        Active, not recruiting
        • Healthy Nurses
        • Educational Activities
        • Simulation in basic life support training (SBLST)
        • standard treatment by using an AHA-BLS 2020 brochure
        • Amman, Jordan
          Ministry of Health
        Aug 16, 2023

        Neuroendocrine Tumors Trial in Seoul (Lanreotide autogel)

        Recruiting
        • Neuroendocrine Tumors
        • Lanreotide autogel
        • Seoul, Korea, Republic of
          Changhoon Yoo
        Jul 18, 2022

        Bone Metastases in neurOendocrine NEoplasms: naTural History,

        Unknown status
        • Bone Metastases
        • Neuroendocrine Neoplasm
          • Milan, Italy
            European Institute of Oncology, IEO, IRCCS
          Jan 20, 2021

          Fatigue and Quality of Life in Neuroendocrine Neoplasia

          Unknown status
          • Neuroendocrine Tumors (NET) Health Related Qualito of Life (HRQoL)
          • Somatostatin analog
          • Aarhus, Denmark
            Gitte Dam
          Sep 14, 2020